Residency · Residency · Emergency Medicine · includes a quiz
ACLS Beyond the Algorithm: Optimizing Cardiac Arrest Resuscitation
Pathophysiology of Cardiac Arrest
Mechanisms of Arrest
Cardiac arrest rhythms fall into two broad categories based on the underlying problem. Ventricular fibrillation and pulseless ventricular tachycardia are shockable rhythms — they represent primarily electrical disorders of the heart. Pulseless electrical activity (PEA), where organized electrical activity persists without effective mechanical contraction, and asystole, the complete absence of ventricular electrical activity, are non-shockable rhythms that typically reflect underlying circulatory failure. This distinction matters because it drives treatment: electrical problems need defibrillation, while circulatory problems need identification and correction of the root cause.
Coronary Perfusion Pressure (CPP)
Coronary perfusion pressure is the difference between aortic diastolic pressure and right atrial diastolic pressure, and it is the driving force that pushes blood through the coronary arteries during CPR. A CPP greater than 15 mmHg is associated with return of spontaneous circulation (ROSC). Chest compressions generate this pressure, but any interruption causes it to decay rapidly. After a pause, it takes five to ten compressions just to rebuild CPP to its prior level — which is why minimizing interruptions is so critical.
Cerebral Perfusion
The brain tolerates approximately four to six minutes of normothermic anoxia before irreversible injury begins. High-quality CPR generates only 25 to 30 percent of normal cardiac output, and even that limited flow is heavily dependent on compression depth, rate, and full chest recoil. Every parameter of compression quality directly translates into cerebral blood flow and, ultimately, neurologic outcome.
High-Performance CPR
Compression Quality Parameters
The fundamentals of compression quality are well defined: a rate of 100 to 120 per minute, a depth of at least 5 centimeters but no more than 6, full chest recoil between compressions (avoiding the natural tendency to lean on the chest), and minimizing interruptions so that the chest compression fraction exceeds 80 percent. Because compression quality degrades with fatigue, compressors should rotate every two minutes.
| Parameter | Target |
|---|---|
| Rate | 100–120 compressions/min |
| Depth | 5–6 cm (at least one-third AP diameter) |
| Recoil | Full chest recoil between compressions |
| Chest compression fraction | > 80% |
| Compressor rotation | Every 2 minutes |
| Perishock pause | < 5 seconds |
The Pit Crew Model
The pit crew model assigns specific roles to each team member before the resuscitation begins — compressor, airway manager, medication nurse, defibrillator operator, and timekeeper/recorder — with the team leader orchestrating the effort. Rhythm checks are choreographed to last no more than ten seconds. The defibrillator is charged during compressions so that the shock can be delivered immediately after the rhythm check, minimizing the perishock pause. This systematic approach transforms cardiac arrest resuscitation from a chaotic scramble into a coordinated, efficient process.
Ventilation Strategy
Excessive ventilation during CPR increases intrathoracic pressure, reduces venous return, and compromises coronary and cerebral perfusion. Before an advanced airway is placed, the compression-to-ventilation ratio is 30:2. After an advanced airway, compressions become continuous, with one breath delivered every six seconds (ten breaths per minute). Passive oxygenation using a non-rebreather mask or an oropharyngeal airway with continuous oxygen flow through a bag-valve mask is an emerging strategy that avoids the hemodynamic costs of positive-pressure ventilation entirely.
Defibrillation Optimization
Timing and Technique
Early defibrillation is the single most important intervention for VF and pulseless VT. When the first shock is delivered within three to five minutes, survival rates reach 50 to 70 percent. Each additional minute of delay reduces survival by 7 to 10 percent. Modern defibrillators use biphasic waveforms as standard, with escalating energy protocols that vary by manufacturer.
Refractory VF
When VF persists after three or more shocks, it is classified as refractory. At this point, consider double sequential defibrillation — using two defibrillators simultaneously with anterior-posterior and anterior-lateral pad positions. The evidence for this approach is limited to case series, but the biologic rationale is plausible: delivering energy from two vectors may depolarize more myocardium simultaneously. Changing pad position, if the initial placement is failing, is a simple intervention worth trying. Pharmacologically, amiodarone 300 mg IV followed by 150 mg is the standard antiarrhythmic for refractory VF.
Pharmacology in Cardiac Arrest
Epinephrine
The standard dose is 1 mg IV or IO every three to five minutes. Its primary benefit in cardiac arrest comes from alpha-1-mediated vasoconstriction, which increases coronary and cerebral perfusion pressure. The landmark PARAMEDIC2 trial (2018) clarified what epinephrine actually does: it improved ROSC rates and 30-day survival, but it did not improve neurologically intact survival. This means epinephrine gets more hearts beating again, but it does not necessarily save more brains. Earlier administration — within the first five minutes — may confer greater benefit in non-shockable rhythms. High-dose epinephrine (0.1 to 0.2 mg/kg) has been abandoned because it worsened neurologic outcomes.
Amiodarone and Lidocaine
For refractory VF or pulseless VT, amiodarone is given at 300 mg IV for the first dose and 150 mg for the second. Lidocaine at 1 to 1.5 mg/kg IV is an alternative. The ALPS trial found that neither drug significantly improved survival to hospital discharge, though there was a trend favoring amiodarone in bystander-witnessed arrests.
Vasopressin
Vasopressin was removed from the ACLS algorithm in 2015 because it showed no benefit over epinephrine alone. Some centers still use a vasopressin-epinephrine-methylprednisolone (VSE) bundle based on limited evidence, but this is not standard practice.
Sodium Bicarbonate
Routine bicarbonate administration is not recommended. It is reserved for specific situations: hyperkalemia-induced arrest, tricyclic antidepressant overdose, or prolonged arrest with severe acidosis. The dose is 1 mEq/kg IV.
Calcium
Like bicarbonate, calcium is not given routinely. Its indications are hyperkalemia, hypocalcemia, and calcium channel blocker overdose.
| Drug | Dose | Indication | Key Notes |
|---|---|---|---|
| Epinephrine | 1 mg IV/IO q3–5 min | All arrest rhythms | Improves ROSC, not neurologically intact survival (PARAMEDIC2) |
| Amiodarone | 300 mg IV first, 150 mg second | Refractory VF/pVT | Trend toward benefit in witnessed arrests (ALPS) |
| Lidocaine | 1–1.5 mg/kg IV | Alternative for refractory VF/pVT | Faster onset than amiodarone |
| Sodium bicarbonate | 1 mEq/kg IV | Hyperkalemia, TCA overdose, severe acidosis | Not routine |
| Calcium | 10 mL of 10% CaCl₂ IV | Hyperkalemia, hypocalcemia, CCB overdose | Not routine |
Reversible Causes (H's and T's)
The H's and T's represent the treatable causes of cardiac arrest that must be systematically considered during every resuscitation. The H's include hypovolemia (treated with fluid resuscitation and blood products), hypoxia (oxygenation and advanced airway management), hydrogen ion excess or acidosis (ventilation and bicarbonate if indicated), hypo- or hyperkalemia (calcium, insulin and glucose, albuterol), and hypothermia (rewarming). The T's include tension pneumothorax (needle or finger thoracostomy), cardiac tamponade (pericardiocentesis or thoracotomy), toxins (specific antidotes), coronary thrombosis (consideration of percutaneous coronary intervention), and pulmonary thrombosis (thrombolytics, with consideration of 50 mg tPA).
| H's | Treatment | T's | Treatment |
|---|---|---|---|
| Hypovolemia | Fluids, blood products | Tension pneumothorax | Needle/finger thoracostomy |
| Hypoxia | Oxygenation, advanced airway | Tamponade (cardiac) | Pericardiocentesis, thoracotomy |
| Hydrogen ion (acidosis) | Ventilation, bicarbonate | Toxins | Specific antidotes |
| Hypo-/Hyperkalemia | Calcium, insulin/glucose, albuterol | Thrombosis (coronary) | PCI consideration |
| Hypothermia | Rewarming | Thrombosis (pulmonary) | Thrombolytics (tPA 50 mg) |
Post-Arrest Considerations in the ED
Immediately after ROSC, a 12-lead ECG should be obtained to evaluate for ST-elevation myocardial infarction. Hemodynamic targets include a mean arterial pressure above 65 mmHg and a systolic blood pressure above 90 mmHg. Hyperoxia should be avoided by titrating the FiO2 to maintain an SpO2 of 94 to 98 percent. Hyperventilation is equally harmful — the PaCO2 target is 35 to 45 mmHg. A discussion about targeted temperature management should be initiated early.
Duration of Resuscitation
There is no absolute time-based cutoff for terminating resuscitation. The decision should integrate the duration of the arrest, the underlying etiology, the initial rhythm, and end-tidal CO2 trends. An ETCO2 below 10 mmHg after 20 minutes of high-quality CPR is associated with very poor outcomes. However, prolonged resuscitation may be appropriate in hypothermia, toxicologic causes, or pulmonary embolism. BLS and ALS termination-of-resuscitation rules provide structured guidance for field decisions.
<image>A detailed medical illustration showing the pit crew model for cardiac arrest resuscitation from an overhead view. Six team members are positioned around a patient on a stretcher in an emergency department resuscitation bay. Each team member is color-coded and labeled with their role: team leader at the head, compressor at the side, airway manager at the head, medication nurse at the IV arm, defibrillator operator across from the compressor, and recorder standing back with a clipboard. Arrows indicate the flow of communication directed through the team leader. Equipment is laid out systematically around the patient.</image>
<image>A physiologic diagram illustrating coronary perfusion pressure during CPR. The top panel shows an arterial waveform and a right atrial pressure waveform during chest compressions, with the diastolic phase highlighted where coronary perfusion occurs. The bottom panel shows a graph of CPP over time, demonstrating the rapid decay of CPP during a compression pause and the gradual rebuilding over 5-10 compressions when CPR resumes. Key threshold of 15 mmHg for ROSC is marked with a dashed line.</image>
<image>An infographic-style illustration comparing the PARAMEDIC2 trial outcomes. Two columns compare epinephrine versus placebo groups. Top row shows ROSC rates (36.3% vs 11.7%), middle row shows 30-day survival (3.2% vs 2.4%), bottom row shows favorable neurologic outcome at hospital discharge (2.2% vs 1.6%), with the last comparison marked as "not statistically significant." Visual emphasis on the disconnect between ROSC improvement and neurologically intact survival.</image>
Clinical Pearls
Compression fraction above 80 percent is the single most modifiable factor in CPR quality — every pause erodes the coronary perfusion pressure you have been building. Pre-charging the defibrillator during compressions minimizes the perishock pause, which should be targeted at less than five seconds. Epinephrine improves ROSC, but its effect on neurologically intact survival remains uncertain based on the PARAMEDIC2 data, so it should never be treated as a substitute for high-quality compressions and rapid defibrillation. End-tidal CO2 monitoring serves double duty as both the best real-time indicator of CPR quality and a prognostic tool. Rather than relying on epinephrine alone, always work through the H's and T's systematically to identify and treat reversible causes. Hyperventilation during CPR is extremely common and harmful — assigning someone specifically to monitor ventilation rate is a worthwhile practice. In refractory VF, double sequential defibrillation and pad repositioning should be considered before concluding the resuscitation is futile. Finally, debriefing every resuscitation is the highest-yield educational intervention in cardiac arrest care.
References
- Olasveengen TM, et al. PARAMEDIC2: Adrenaline in out-of-hospital cardiac arrest. NEJM. 2018;379:711-721.
- Kudenchuk PJ, et al. ALPS Trial: Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. NEJM. 2016;374:1711-1722.
- Panchal AR, et al. 2020 AHA Guidelines for CPR and ECC. Circulation. 2020;142(suppl 2).
- Cheskes S, et al. Perishock pause and chest compression fraction in cardiac arrest. Resuscitation. 2011;82:1501-1506.
- Meaney PA, et al. CPR quality: Improving cardiac resuscitation outcomes both inside and outside the hospital. Circulation. 2013;128:417-435.


